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Heart growthTbx2 is a member of the T-box family of transcription factors that play important roles during heart
development. In the embryonic heart tube, Tbx2 is expressed in non-chamber myocardium (outﬂow tract
and interventricular canal) and has been shown to block chamber formation. We have developed a genetic
system to conditionally misexpress Tbx2 in the embryonic mouse heart at early stages of development. We
show that Tbx2 expression throughout the myocardium of the heart tube both represses proliferation and
impairs secondary heart ﬁeld (SHF) progenitor cell deployment into the outﬂow tract (OFT). Repression of
proliferation is accompanied by the upregulation of Ndrg2 and downregulation of Ndrg4 expression, both
genes believed to be involved in cell growth and proliferation. Impaired deployment of SHF cells from the
pharyngeal mesoderm is accompanied by downregulation of the cell adhesion molecules Alcam and N-
cadherin in the anterior part of the embryonic heart. Tbx2 misexpression also results in downregulation of
Tbx20 within the OFT, indicating complex and region-speciﬁc transcriptional cross-regulation between the
two T-box genes.Crown Copyright © 2009 Published by Elsevier Inc. All rights reserved.IntroductionIn mammals and birds, the embryonic heart undergoes rapid
expansion and growth during the ﬁrst half of gestation as the linear
peristaltic tube is transformed into a complex, four-chambered organ
supporting embryo growth (Buckingham et al., 2005). The heart tube
of the mouse embryo for example, grows over 4-fold in length
between E8 and E9 (Kelly et al., 2001), with an estimated 9.5-fold
increase in cell number by the time primitive chambers have formed
(Meilhac et al., 2003).
Until relatively recently, dramatic growth of the embryonic heart
was assumed to be the result of high levels of cell proliferation, which
are known to occur, for example, during formation of primitive atrial
and ventricular chambers (Cai et al., 2005). However, quantitative
measurements of cell division within the looping heart tube indicate
that regional changes in proliferation are surprisingly modest during
this period (Soufan et al., 2006). The bulk of growth in the early heart
tube appears from lineage labelling (Abu-Issa et al., 2004) and
quantitative proliferation studies (van den Berg et al., 2009), to result
from addition of adjacent mesodermal cells to either pole of the
developing heart tube. Such cells (often termed the secondary heart
ﬁeld or SHF) ultimately contribute to a major portion of the mature
organ, those added at the arterial pole forming both the outﬂow tract
(OFT) and the right ventricle (Kelly et al., 2001; Zaffran et al., 2004).).
09 Published by Elsevier Inc. All rigMovement of tissue from the splanchnic and pharyngeal meso-
derm into the developing heart appears to commence shortly after the
fusion of the cardiac crescent, and in the mouse, addition is largely
complete by E10.5 (Kelly et al., 2001; Park et al., 2006; Sun et al., 1999).
Growth of the early heart tube appears therefore to be largely
driven by a proliferative centre within the mesoderm of the caudal
coelomic wall, which provides an expanding pool of heart ﬁeld
progenitors that are added to the initial heart tube (van den Berg et al.,
2009). Elucidating the mechanisms that regulate deployment of SHF
cells is therefore decisive for understanding growth and differentia-
tion of the early heart.
The T-box family of transcription factors play important roles in
organogenesis (Naiche et al., 2005), including that of the heart. At
least seven T-box genes are expressed in the developing vertebrate
heart: Tbx1-5, Tbx18 and Tbx20 (Stennard and Harvey, 2005). Whilst
several show overlapping expression patterns, experimental studies
reveal that each has a unique developmental function (Hoogaars et al.,
2007; Stennard and Harvey, 2005). In the early stages of cardioge-
nesis, Tbx2 is believed to play an important role. In the mouse embryo
(E9.5), Tbx2 expression is restricted to non-chamber myocardium,
most notably the atrioventricular canal (AVC), inner curvature and
OFT, where it is believed to repress differentiation of ventricular and
atrial myocardium (Christoffels et al., 2004; Habets et al., 2002;
Harrelson et al., 2004). Consistent with this, Tbx2-null embryos show
anomalies of the AVC and defects in OFT alignment (Harrelson et al.,
2004). Conversely, ectopic expression of Tbx2 in pre-chamber
myocardium results in a loss of chamber differentiation and
morphogenesis (Christoffels et al., 2004).hts reserved.
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Tbx20. In humans, mutations of this factor are associated with diverse
cardiac pathologies (Kirk et al., 2007). In the mouse, Tbx20 is
expressed throughout themyocardium, endocardium and endocardial
cushions of the mid-gestation heart (Stennard et al., 2003, 2005;
Takeuchi et al., 2005). In Tbx20 mutant hearts, Tbx2 is misexpressed
broadly suggesting that Tbx20 negatively regulates Tbx2 (Cai et al.,
2005; Singh et al., 2005; Stennard et al., 2005; Takeuchi et al., 2005).
The similarity in cardiac phenotype between the Tbx20 null and Tbx2
misexpression embryos supports this interpretation (Cai et al., 2005;
Christoffels et al., 2004; Singh et al., 2005; Stennard et al., 2005).
To date, the regulatory interactions between Tbx2 and Tbx20 have
largely been studied through their impact on the differentiation of
cardiac chambers from the heart tube. However, many T-box factors
have also been shown to play a role in cell migration (Naiche et al.,
2005). For example, injection of Tbx20 mRNA into Xenopus embryos
not only induces mesodermal and endodermal lineage markers, but
also cell migration via non cell-autonomous mechanisms (Stennard
et al., 2003). Expression of Tbx2 and Tbx20 in the OFT therefore raises
the possibility that these transcription factors may also play some role
in the deployment of cardiac progenitor cells into the heart from the
SHF (Singh et al., 2005; Stennard et al., 2005).
Here we report studies using a binary genetic approach to
manipulate expression of the T-box transcription factor, Tbx2. We
show that early Tbx2 misexpression throughout the myocardium
causes severe defects in patterning of the anterior heart tube and in
subsequent heart growth. Reduced heart size is due not only to a
decrease in myocardial cell proliferation, but also to a defect in
deployment of Isl1+ cardiac progenitor cells from the SHF into the
anterior end of the cardiac tube. These results demonstrate that the
Tbx2 regulatory network is essential for cardiac growth, both through
proliferation and correct deployment of SHF progenitors.
Materials and methods
Transgenic lines
The tetO-Tbx2, tetO-Tbx20 and xMlc2-rtTA transgenes are detailed
in Fig. S1A. Isl1-cre and R26R-YFP indicator mice have been previously
described (Srinivas et al., 2001). Doxycycline was administered to
pregnant females either by intraperitoneal injection (2 mg of Dox in
0.5ml of 0.9% aqueous NaCl) at the indicated stage or via food (2mg of
Dox in 0.5 ml of 0.9% aqueous NaCl) from stages speciﬁed.
qRT-PCR
mRNAwas isolated from dissected hearts and analysed by qPCR as
described previously (Risebro et al., 2006). All experiments were
carried out in triplicate and at least three different samples were
quantiﬁed for each experiment. Student's t-test was used for analysis
of statistical signiﬁcance.
Histology, BrdU incorporation and TUNEL experiments
Embryos were ﬁxed with 4% paraformaldehyde, dehydrated and
embedded in BDH Fibrowax. Serial 10 μm sections were counter-
stained with 0.5% Eosin. For BrdU incorporation, pregnant females
were injected intraperitoneally with 100 μg/g body weight of BrdU
(Sigma) and sacriﬁced after 1 h. TUNEL staining was carried out using
the supplier's instructions (ApopTag Kit, Qbiogene).
Immunoﬂuorescence
Embryos were dissected, ﬁxed with 4% PFA for 20 min and
embedded in gelatin before cryosectioning. Sections were stained
with antibodies against β-catenin (1/100; Sigma), BrdU (1/100;DSHB), cleaved caspase 3 (1/100; Cell Signalling), GFP (1/1000;
Molecular Probe), phospho-histone H3 (1/100; Upstate), Isl1 (1/50;
DSHB), N-cadherin (1/100; Abcam), Nkx2.5 (1/100; Santa Cruz), p57
(1/100; Lab Vision), Pecam (1/50; BD Pharmingen) and Tbx2 (1/50;
Upstate). Sections were then counterstained with Dapi (Biotium, Inc.)
and mounted in Mowiol. Images were captured using an LSM5 Pascal
confocal microscope (Zeiss, Germany).
In situ hybridisation
RNA in situ hybridisation (Dupays et al., 2005), were performed
using the following RNA probes: Tbx2 (Paxton et al., 2002; a gift from
Christian Paxton), N-myc1, CcnA2 and Wnt11 (Cai et al., 2005; a gift
from Sylvia Evans), Bmp2 (a gift from Bridgid Hogan), Bmp10
(Neuhaus et al., 1999; a gift from Vicki Rosen), Tbx20 (Stennard
et al., 2003; a gift from Richard Harvey). Ndrg2, Ndrg4 and Alcam
riboprobes were synthesised from whole IMAGE clones 4211421,
3156802 and 3501215 respectively.
OPT
Optical projection tomography (OPT) and visualisation was
performed as previously described (Breckenridge et al., 2007).
Results
Inducible myocardial expression of a Tbx2 transgene
In order to achieve targeted misexpression of Tbx2 in the
myocardium of the embryo, we used a binary genetic system with
the pan-myocardial xMLC2 promoter (Latinkic et al., 2004). We used
transgenic mice bearing the reverse tetracycline responsive transacti-
vator (rtTA) fusion protein under the control of the XMLC2 promoter
(xMlc2-rtTA;Breckenridge et al., 2009; Fig. S1A) and tested founders
by crossing with the tetO-LacZ reporter line (Redfern et al., 1999).
Pregnant females were induced at E8.5 with doxycycline (see
Materials and methods) and embryos removed 24 h later. β-
galactosidase activity was restricted to the embryonic heart of double
transgenic (XMLC2-rtTA/tetO-lacZ) embryos at E9.5 and similar results
were obtained at all other embryonic stages tested (Fig. S1B). No
difference in tissue speciﬁcity was observed between different
founders (data not shown).
Four separate mouse lines bearing a binary target Tbx2 transgene
(tetO-Tbx2; Fig. S1A) were also established. Founders for each tetO-
Tbx2 line were crossed with the XMLC2-rtTA transactivator line and
double transgenic embryos tested by RNA whole-mount in situ
hybridisation for induction of Tbx2 expression. Using either intraper-
itoneal injection or food supplementation to administer doxycycline
from E7.5, Tbx2mRNA expression in the heart was increased by about
20-fold in double transgenic (XMLC2-rtTA/tetO-Tbx2) embryos, as
assessed by qRT-PCR at E9.5 when compared to controls (Fig. S1C).
Similar levels were found in all four lines tested and subsequent
studies were therefore performed using a single line.
After administration of doxycycline at E7, Tbx2 can be detected by
in situ hybridisation as early as E7.5 in the cardiac crescent, prior to the
normal onset of Tbx2 expression (compare Figs. 1A and B; Christoffels
et al., 2004). At E8.5, endogenous Tbx2 can be detected in the more
caudal part of the embryonic heart, but in induced double transgenic
embryos the Tbx2 transgene is expressed strongly throughout the
whole cardiac tube (compare Figs. 1C and D). To determine the
kinetics of Tbx2 activation, we dissected embryos at successive times
following intraperitoneal injection of doxycycline. In the E9.5 looped
heart tube, Tbx2 is expressed in the myocardium of the OFT, inner
curvature, AVC and inﬂow tract (Fig. 1E; Christoffels et al., 2004;
Harrelson et al., 2004). In contrast, after as little as 6 h of induc-
tion, double transgenic embryos show prominent Tbx2 transgene
Fig.1. Comparison of Tbx2 and Tbx20 expression in control andmisexpressing embryos. Control embryos xMlc2-rtTA−/tetO-Tbx2+: panels A, C, E and G; xMlc2-rtTA−/tetO-Tbx20+:
panel I. Misexpressing embryos xMlc2-rtTA+/tetO-Tbx2+: panels B, D, F and H; xMlc2-rtTA+/tetO-Tbx20+: panel J. At E7.5, no Tbx2 can be detected in the cardiac crescent in normal
embryos, whilst a strong signal is observed inmisexpressing embryos (compare A and B; red arrows). At E8.5, endogenous Tbx2 expression can be detected in the posterior part of the
heart tube of control embryos, and throughout the length of the tube in misexpressing embryos (C and D; red arrows). At E9.5, transcripts are localised to the AVC and OFT of control
embryos but are heavily expressed in all regions of the heart in misexpressing embryos (E and F; red arrows). At E11.5, endogenous Tbx2 protein can be detected by
immunohistochemistry in Nkx2-5-positive cardiomyocytes of the AVC (G; white arrows) and in Nkx2-5-negative cells of endocardial cushion (G; red arrows). At the same stage in
misexpressing embryos (induced for 24 h), Tbx2 protein is evident throughout Nkx2-5 positive tissue of the heart and in Nkx2-5-negative endocardial cushions (H; white and red
arrows, respectively). Insets in G and H show high magniﬁcation of boxed area. In control embryos, Tbx20 is detected in the heart by in situ hybridisation, with enhanced expression
in the AVC and OFT (I; red arrows). Induction of Tbx20 misexpression results in enhanced signal throughout the heart tube (J) but has no effect on heart morphology. Endogenous
expression of Tbx20 remains the same in both genotype (compare white arrows in I and J). Scale bars=100 μm. Time of doxycycline administration is indicated.
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how tightly controlled expression of the transgene was using the rtTA
binary system, we examined Tbx2 expression at E9.5 in single
transgenic (tetO-Tbx2) embryos induced from E7.5, along with double
transgenic embryos that were not exposed to doxycycline inducer. In
neither case could we detect any misexpression of Tbx2 by in situ
hybridisation (Fig. 1E and data not shown), indicating that in early
embryos the transgene remained inactive in the absence of either the
rtTA transactivator or the doxycycline inducer.
Expression of the induced Tbx2 transgene is evidently mosaic
at each stage analysed (Fig. 1, panels B, D and F). Previous studies
have demonstrated that whilst the XMLC2-rtTA driver confers pan-
myocardial tissue speciﬁcity, the resulting expression of any responder
transgene is always mosaic (Breckenridge et al., 2009; Fig. S1B and
unpublished data). We presume this results from variable expression
of the rtTA transactivator, as high levels of rtTA expression are known
to be essential for dox-dependent expression (Klopotowska et al.,
2008). In order to assess the extent of this mosaicism, we induced
expression of Tbx2 at E10.5, harvested double transgenic embryos at
E11.5 and examined the cellular distribution of Tbx2 protein by
immunohistochemistry. In control embryos, endogenous Tbx2 expres-
sion is weakly detected in the myocardium of the atrioventricular
junction (Fig. 1G); in the induced double transgenic embryos, Tbx2
expression is readily apparent throughout the myocardium, including
atrial and ventricularwalls aswell as the atrioventricular junction (Fig.
1H). We have quantiﬁed mosaicism in three embryos at E9.0, all of
which showed the less severe morphological phenotype (see below).
All three showed similar levels of mosaicism, as judged by comparison
of MF20 (muscle) and Tbx2 immunostaining. At this developmental
stage we ﬁnd that 82.1% (+/−4.95%) of MF20 positive cells were also
positive for Tbx2 (Fig. S4).Misexpression of Tbx2 causes severe ventricular hypoplasia
Transgene induction at the onset of cardiac development (E7.5)
dramatically affected cardiac morphology, resulting in a poorly looped
and severely hypoplastic heart tube (Fig. S2F). By E9.5, embryos
showed gross developmental retardation, an enlarged pericardial
cavity, oedema and the absence of blood circulation, all indicating that
subsequent death by E10 resulted from cardiovascular defects. In
order to test whether the phenotype was speciﬁc for Tbx2, we also
generated mutant mice misexpressing the related T-box factor, Tbx20.
Like Tbx2, Tbx20 has been shown to act as a transcriptional repressor,
directly repressing, for example, Tbx2, Isl1 and ANF genes (Cai et al.,
2003; Plageman and Yutzey, 2004). After administration of doxycy-
cline from E7, Tbx20-misexpressing embryos were analysed at E9.5,
E10.5 and E12.5. Whole mount in situ hybridisation and immunos-
taining conﬁrmed that Tbx20 was misexpressed in response to the
inducer but the embryos were morphologically indistinguishable
from their control littermates (compare Figs. 1I and J; data not
shown). This is in striking contrast to the profound effects of Tbx2
misexpression.
Histological analysis revealed that the defects resulting from Tbx2
misexpression were largely restricted to the anterior region of the
heart tube.Whilst the common atrium of the induced hearts appeared
largely normal, the ventricular region was dramatically reduced and
its lumen frequently occluded or indiscernible (Fig. S2). Induced
embryos lacked the endocardial cushions characteristic of the
atrioventricular junction at this stage of development; their branchial
arch arteries were also massively enlarged, presumably as a secondary
consequence of cardiac dysfunction.
Imaging of induced embryos by optical projection tomography
revealed a range of morphological phenotypes (Fig. 2). The least
Fig. 2. Volume-rendered optical projection tomography of embryonic hearts at E9.5, viewed from right, ventral and left view. A–C: control embryos (containing the responder line);
D–F: misexpressing hearts with a moderate phenotype; G–I: misexpressing hearts with a severe phenotype. (ctrl: control; mis: misexpressing; OFT: outﬂow tract; A: atria; V:
ventricle; arrow: sulcus.). Doxycycline administered at E7.
124 L. Dupays et al. / Developmental Biology 333 (2009) 121–131affected embryos (Figs. 2D–F) show a profound reduction in size of
the ventricular region and an unlooped heart tube. A distinct and
normal sized common atrial chamber is retained, as is a constriction
(sulcus) separating the putative embryonic ventricle from the OFT
region (Fig. 2E, arrow). Approximately 10% of induced embryos
show a more severe phenotype, in which the ventricular portion of
the heart tube is almost completely absent and the OFT is severely
truncated (Figs. 2G–I). In these embryos, a relatively normal sized
atrial chamber connects directly to the reduced OFT and the heart
tube remains aligned along the body midline, with no discernable
looping.
Tbx2 represses expression of chamber differentiation markers
Expression of markers characteristic of differentiated cardiac
chamber myocardium (such as Cx40, Chisel and ANF) is reduced in
the Tbx2-misexpressing hearts (Fig. 3A) consistent with previous
reports (Christoffels et al., 2004), whilst levels of the more widely
expressed transcription factors Gata4, Mef2c and Srf remain unaf-
fected. Tbx2misexpression also results in the loss of Bmp10 expression
from the heart tube (Fig. 3, compare B and C). This growth factor is
normally expressed from E9.5 in the developing trabeculae of the
heart (Neuhaus et al., 1999) and is believed to be important in
maintaining cardiac growth (Chen et al., 2004; Pashmforoush et al.,
2004). To distinguish whether loss of Bmp10 is a result of transcrip-
tional repression by Tbx2 or a secondary consequence of retarded/
arrested heart development, we induced Tbx2misexpression at E10.5,
24 h after the normal onset of Bmp10 expression. Under these
circumstances, misexpression of Tbx2 again results in the reduction of
the chamber differentiation marker, Cx40 (8.4-fold) but the effect
on Bmp10 is much more modest (1.7-fold) (Fig. 3D). This sug-
gests that repression of Bmp10 by Tbx2 is unlikely to be direct, its
reduced expression being the consequence of impaired myocardial
differentiation.Disruption of anteroposterior patterning
At E8.5 and E9.5, Nkx2.5 expression can be detected by immunos-
taining throughout the Tbx2 misexpressing heart, indicating that
myocardial cells are present along the length of the embryonic heart
tube (Fig. 7B and data not shown). Furthermore, a restricted domain of
Bmp2 expression is retained in these hearts (Fig. 4), indicating that a
distinct AVC region is maintained (Ma et al., 2005). In contrast,
expression ofWnt11, which provides a marker of the OFT myocardium
at E8.5 (Cai et al., 2003), is strongly reduced in misexpressing hearts,
indicating that myocardium of the OFT is poorly differentiated
(compare Figs. 4 C and D). Consistent with this, expression of the T-
box factor Tbx20 is also altered by Tbx2 misexpression. In normal
embryos, Tbx20 is expressed throughout myocardium and endocar-
dium, with high levels noted in endocardial cushions, themyocardium
surrounding the AV canal and the OFT (Cai et al., 2005; Singh et al.,
2005; Stennard et al., 2005). Moreover, Tbx2 has been shown to be
upregulated in Tbx20mutant hearts (Cai et al., 2005; Singh et al., 2005;
Stennard et al., 2005). In Tbx2-misexpressing hearts, Tbx20 expression
is barely detectable in the more anterior OFT region from E8.5 to E9.5,
whilst expression in the remainder of the heart tube is unaffected (Fig.
4, compare E, G and I with F, H and J). Together, these results indicate
that Tbx2misexpression disrupts normal patterning of the heart tube,
speciﬁcally disrupting patterning and/or differentiation of the anterior
OFT region. They also suggest that regulatory crosstalk can occur
between Tbx2 and Tbx20 in the arterial pole of the developing heart.
Proliferation but not apoptosis is affected in the Tbx2-misexpressing
heart
The reduction in cardiac tube myocardium in induced hearts could
be the result of increased cell death, a decrease in cell proliferation, or
both. TUNEL assays showed no differences in apoptosis between
control and Tbx2-misexpressing embryos at E8.5 (Fig. S3A and B).
Fig. 3. Quantitative real-time PCR analysis on RNA extracted from control or Tbx2-misexpressing hearts for an array of cardiac markers at E9.5 (A) and E11.5 (D). (B, C) in situ
hybridisationwith Bmp10 probe in E9.5 embryonic hearts. (Measurements aremean±s.e.m., values of n=3 for each genotype. ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.001, n.s.: non signiﬁcant).
Time of doxycycline administration is indicated.
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show no signiﬁcant change in activated Caspase 3 staining (data not
shown). However, whole-mount immunostaining for phosphorylated
histone H3 revealed a decrease in proliferation in Tbx2-misexpressing
hearts relative to controls between E8.0 and E9.5 (Fig. S3) and similar
results were obtained from BrdU labelling (Fig. 5). At E8.5, 21.4% of
Nkx2.5-positive cells in control hearts were BrdU-positive, but this
was reduced to 11.9% in Tbx2-misexpressing hearts (n=3 for each
genotype). Proliferative defects were not obviously restricted to
particular regions of the heart. Reduced myocardial cell prolifera-
tion is therefore a signiﬁcant cause of the cardiac tube hypoplasia in
Tbx2-misexpressing hearts.
Ndrg4 is downregulated and Ndrg2 upregulated in the
Tbx2-misexpressing heart
It has previously been reported that expression of both N-myc1 and
Ccna2 (cyclin A2) are downregulated in Tbx20mutant mouse hearts atFig. 4. Whole mount in situ analysis of Tbx2-misexpressing embryos and control littermat
expression is maintained despite Tbx2misexpression. (C, D)Wnt11 is expressed in the OFTof
(E–J) In control embryos, Tbx20 is expressed in thewhole heart at E8.5 (E, F: ventral view; G, H
in Tbx2-misexpressing embryos (compare brackets in E, G, I and F, H, J). Doxycycline adminE9.5(Caiet al.,2005), reﬂectingeitherdirect transcriptional activationby
Tbx20 or repression by Tbx2, which is itself upregulated throughout the
heart tube of thesemutants (Cai et al., 2005; Singh et al., 2005; Stennard
et al., 2005). In principle, these alternatives could be distinguished by
examining directly the effect of Tbx2 overexpression on N-myc1 and
Ccna2 expression. However, we have been unable to detect any
expression of these factors within the wild type heart tube at E9.5,
despite clear expression in other parts of the embryo (data not shown).
We have therefore only been able to assess whether loss of N-myc1 and
Ccna2may be a result of transcriptional repression by Tbx2 by inducing
Tbx2misexpression at the later stage of E10.5 and assessing its effect at
E11.5. Under these conditions, expression of N-myc1 and Ccna2 in the
outer proliferative, compact layer of the ventricular wall and the base of
the interventricular septum is lost on induction of Tbx2 misexpression,
whilst other domains of their expression within the embryo are
unaffected (Figs. 6A–D). Both genes could therefore be downregulated
in response to elevated Tbx2 levels but we cannot demonstrate such
regulation in the looping heart tube.es. (A, B) Bmp2 is expressed in the AVC canal of E9.5 control embryonic heart and its
E8.5 control embryonic heart but its expression is reduced in hearts misexpressing Tbx2.
: right side view) and E9.5 (I, J), but its expression in the OFT is severely downregulated
istered at E7.
Fig. 5. Analysis of cell proliferation at E8.5 in transverse sections of control (A and C) and misexpressing hearts (B and D). Sections were analysed by confocal microscopy for BrdU
incorporation (green) and Nkx2-5 protein distribution (red); nuclei were stained with DAPI (blue). White boxes in A and B indicate a highmagniﬁcation view in C and D respectively.
(E) Quantiﬁcation of cell proliferation by the ratio of BrdU-positive cells to Nkx2.5-positive cardiomyocytes. The proliferation index is signiﬁcantly reduced in the misexpressing
hearts when compared with control. (⁎⁎Pb0.01. Scale bars=100 μm). Doxycycline administered at E7.
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has also been suggested as a regulator of cardiac proliferation
(Kochilas et al., 1999). Expression of p57kip2 is induced in the
hearts of Bmp10 null embryos at E9.5 and such precocious
expression could account for the failure of normal chamber
differentiation in these embryos (Chen et al., 2004). However,
distribution of p57kip2 protein in cardiomyocytes of the embryonic
heart at E9.5 was unaffected by Tbx2 misexpression (Fig. 6,
compare E, G with F, H).
In contrast, two members of the cell growth and differentiation-
related NDRG gene family (Qu et al., 2002) are affected by Tbx2
misexpression. Ndrg2, a candidate tumour suppressor (Deng et al.,
2003) shows an expression pattern in the normal heart tube that is
remarkably similar to that of Tbx2 (compare Figs. 1E and 6K; Okuda
and Kondoh, 1999b), suggesting it may act as a repressor of
cardiomyocyte proliferation. Consistent with this, induction of Tbx2
throughout the early heart tube resulted in expansion of Ndrg2
expression to include the entire heart tubemyocardium at E8.5 (Fig. 6,
compare I and J) and E9.5 (Fig. 6, compare K and L). Additionally, Tbx2
misexpression results in downregulation of the related NDRG family
member Ndrg4, within the ventricular part of the E8.5 heart (Fig. 6,
compare M and N). In zebraﬁsh embryos, loss of Ndrg4 function
results in reduced myocardial proliferation and growth (Qu et al.,
2008) and in the mouse its reduction in response to Tbx2 misexpres-
sion may therefore contribute to the proliferation defect we observe.
Both Ndrg2 and Ndrg4 contain conserved T-box binding sites within
their proximal promoters (Fig. S6).
Tbx2 misexpression impairs deployment of SHF-derived cardiomyocytes
To test whether impaired deployment of SHF cells contributes to
the failure in heart tube morphogenesis seen in Tbx2-misexpressing
embryos, we combined our binary induction systemwith Isl1-cre and
R26R-YFP alleles (Srinivas et al., 2001) to facilitate lineage analysis of
Isl1-expressing cardiac progenitors cells (Cai et al., 2003).
Isl1 protein is observed in the pharyngeal mesoderm and distal
portion of the OFT in control (XMLC2-rtTA−/tetO-Tbx2+/Isl1-cre+/
R26R-YFP+) and mutant (XMLC2-rtTA+/tetO-Tbx2+/Isl1-cre+/R26R-
YFP+) embryos, reﬂecting the location of SHF cells (Figs. 7C and D).
The slight reduction in Isl1+ cell number in the Tbx2-misexpressing
OFT is consistent with its reduced size.
YFP+ cells can be detected along the entire length of the OFT
in normal hearts, identifying SHF-derived cardiomyocytes. In Tbx2-misexpressing embryos, a broadly similar distribution is evident,
however the number of YFP+ cells appears reduced (Figs. 7E and F).
Finally, it is noteworthy that YFP is co-expressed with Isl1 in pha-
ryngeal mesoderm and distal OFT reﬂecting endogenous Isl1 protein
expression in those regions (Figs. 7G and H). By comparing the ratio of
YFP+ to YFP− cells amongst the Nkx2.5+::Isl− population, we found
that approximately 2.5 times fewer cells from the pharyngeal
mesoderm expand into the OFT of the Tbx2-misexpressing heart
(Fig. 7I), suggesting that a defect in SHF cell deployment may account
for the hypoplastic heart observed in Tbx2-misexpressing embryos.
Alcam and N-cadherin expression is downregulated in the OFT
β-catenin protein has previously been shown to regulate SHF
development and heart tube formation (Ai et al., 2007; Kwon et al.,
2007), however its expression in the heart tube appears unaffected by
Tbx2 misexpression (Figs. 8G and H). SHF deployment, like other
morphogenetic movements, also requires proper cell contacts and
regulated cell adhesion. Alcam, a transmembrane glycoprotein of the
immunoglobulin family superfamily, plays a role in cell migration
(Heffron and Golden, 2000) and is expressed in mouse cardiac tissue
(Hirata et al., 2006). An essential role of Alcam has recently been
identiﬁed in studies of Xenopus cardiac morphogenesis (Gessert et al.,
2008). InTbx2-misexpressinghearts,Alcamexpression isdownregulated
in the anterior part of the heart at E8.5 (Figs. 8A and B); by E9.5, ex-
pression is reduced in thewhole heart and completely absent in the OFT
(Figs. 8C and D). Similarly, another cell adhesion protein essential for
proper heart tube formation, N-cadherin (Radice et al., 1997) is also
downregulated speciﬁcally in the OFT of the misexpressing heart
(Figs. 8E and F). We note that both N-cadherin and Alcam contain con-
served T-box binding sites within their proximal promoters, in the latter
case, closely associatedwith a conserved Nkx2.5 bindingmotif (Fig. S6).
Discussion
A fundamental challenge in cardiac developmental biology is to
understand how the early heart tube initiates complex, regionalised
patterns of differentiation whilst at the same time undergoing
dramatic growth. Little is currently known about how cardiomyocyte
proliferation is regulated; neither do we understand the mechanisms
or signals regulating the elongation of the heart tube by addition of
cardiac precursors at venous and arterial poles. Using a mouse gain-
of-function model, here we provide evidence that the T-box
Fig. 6. (A–D) In situ hybridisation examining N-myc1 and Ccna2 expression on transverse sections of E11.5 embryos. At this stage both genes are expressed in the compact layer of the
myocardium. However, their expression is absent in misexpressing embryos (compare black arrows in A and C with B and D) while their expression is maintained in other tissues
(compare red arrows in A and C with B and D). (E–H) Immunostaining for p57 protein on transverse sections of E9.5 embryos reveals expression in the nuclei of both control and
misexpressing hearts (compare white arrows in E and F). Small numbers of p57-positive nuclei can be found in both cardiomyocytes and endocardial cells, as determined by
colocalisationwith staining for Nkx2.5 and Pecam antibodies respectively. (Compare red arrows in G and H for p57/Nkx2.5 expressing cells andwhite arrows in G andH for p57/Pecam
expressing cells). (I–N) Whole mount RNA in situ hybridisation for Ndrg2 and Ndrg4 at E8.5 (I, J and M, N) and E9.5 (K, L). Ndrg4 expression is downregulated in Tbx2-misexpressing
heart (compare arrows in M and N) whilst Ndrg2 expression is upregulated in E8.5 and E9.5 Tbx2-misexpressing hearts (compare arrows in I and J). Scale bars=100 μm. Time of
doxycycline administration is indicated.
127L. Dupays et al. / Developmental Biology 333 (2009) 121–131transcription factor, Tbx2, plays a role in both processes. Misexpres-
sion of Tbx2 throughout the early heart myocardium results in
decreased cell proliferation and reduced deployment of progenitors
cells from the SHF into the OFT. Together, these result in formation of a
severely hypoplastic heart tube.
Gain-of-function studies have already proved helpful in studying
T-box function in the early heart, but studying signiﬁcant numbers of
embryos is difﬁcult using transient transgenic assays (Christoffels
et al., 2004; Mommersteeg et al., 2007; Takeuchi et al., 2003).
Furthermore, such an approach precludes the use of the increasing
variety of indicator mouse lines that are now available to monitor cell
lineage or gene expression. To overcome these limitations, we have
used a binary genetic approach. This has allowed reliable induction of
pan-myocardial Tbx2 expression in early stages of cardiogenesis, with
no detectable leakage. One serious limitation of gain-of-function
studies is the difﬁculty in interpreting results when misexpressionresults in early embryonic lethality. Under these circumstances, it can
be difﬁcult to distinguish whether altered gene expression (especially
loss of expression) is a direct result of transgene gain-of-function, or a
secondary consequence of arrested heart development. With a binary
system, the ability to induce gain-of-function at different stages of
development goes some way to overcome this difﬁculty.
Tbx2 represses proliferation in the embryonic heart
Tbx2 plays a critical role repressing the transcriptional programme
associated with chamber differentiation (Christoffels et al., 2004;
Habets et al., 2002;Harrelsonet al., 2004). Cell culture studieshave also
demonstrated a role for Tbx2 in cell cycle control (Jacobs et al., 2000;
Prince et al., 2004). However, it is striking that no proliferative
differences were observed in the heart of Tbx2-null mice compared
with wild type littermates (Harrelson et al., 2004). The most likely
Fig. 7. Comparison of control (xMlc2-rtTA−/tetO-Tbx2+/Isl1-cre+/R26R-YFP+) andmutant (xMlc2-rtTA+/tetO-Tbx2+/Isl1-cre+/R26R-YFP+) hearts at E9.0. Scale bar=100 μm. (A,
B): Nkx2.5 protein is observed in virtually all cardiomyocytes of the OFT but absent from endocardial cells (arrows); (C, D): in contrast, Isl1 protein (marking the SHF) is observed
only in the distal OFT (red arrow) and pharyngeal region (white arrow); (E, F) Lineage-labelled cells originating from the SHF are detected (via YFP expression) along the whole
length of the OFT (red arrows) and in the pharyngeal region (white arrow); (G, H): direct overlay shows that Isl1 and YFP staining colocalise only in the distal part of the OFT and
pharyngeal region (arrows). (I): Quantiﬁcation of migrating cells (YFP+/Nkx2.5+/Isl1−)/(Nkx2.5+/Isl1−). 56.3% (±19.2) of migrating cells are YFP+ in the OFT of control hearts,
compared with only 22.9% (±15) in Tbx2-misexpressing hearts. (n=6 for each genotype; ⁎⁎⁎Pb0.001). Doxycycline administered at E7.
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Tbx2 and Tbx3, since these factors show overlapping domains of
expression during heart development (Hoogaars et al., 2004). Inter-
estingly, in contrast to the Tbx2mouse knockout, the Tbx3 null mouse
does showan increase in proliferation at the AV junction (Ribeiro et al.,
2007), suggesting that any functional redundancy is only partial.Fig. 8. (A–D): In situ hybridisation for Alcam expression in E8.5 (A and B, ventral view)
misexpressing hearts (compare brackets A and C with B and D). Immunohistochemistry show
(compare brackets in E and F) where little or no protein can be detected. The distribution of
OFT (compare brackets in G and H). Scale bars=100 μm. Doxycycline administered at E7.Some conservation in the regulatory roles of Tbx2 and Tbx3 across
vertebrates is suggested from studies in zebraﬁsh, but the extent of
this is currently unclear. Misexpression of either factor in zebraﬁsh
embryos results in decreased proliferation in the heart, but the
converse experiment usingmorpholinos to block T-box factor function
has no signiﬁcant effect on the number of proliferating cells in theand E9.5 (C and D, left side view) embryos. Alcam is downregulated in the OFT of
s that N-cadherin distribution is unchanged bymisexpression of Tbx2, except in the OFT
β-catenin protein is similar in control and misexpressing hearts even at the level of the
129L. Dupays et al. / Developmental Biology 333 (2009) 121–131heart tube (Ribeiro et al., 2007). It is unclear whether such
discrepancies between results with mouse and zebraﬁsh embryos
reﬂect signiﬁcant species differences or the differing experimental
techniques used. In light of this, since the mouse Tbx2/Tbx3 double
null phenotype has not been documented, misexpression of Tbx2 is
the only way to investigate its possible role controlling proliferation
during mouse cardiac development.
Upregulation of Tbx2 throughout the heart tube that occurs in
Tbx20-null embryos (Cai et al., 2005; Singh et al., 2005; Stennard et al.,
2005; Takeuchi et al., 2005) is accompanied by reduction in
expression of the cell proliferation regulators, N-myc1 and Ccna2
(Cai et al., 2005). Since both T-box factors bind to the N-myc1
promoter in vivo and act antagonistically in vitro, reduced proliferation
could be due either to loss of Tbx20, to elevated expression of Tbx2, or
a combination of the two. Our studies emphasise the complexity of
these interactions. Direct overexpression of Tbx2 in our binary system
causes a similar downregulation of N-myc1 and Ccna2; however, it
also results in selective repression of Tbx20 in the anterior region of
the heart. Intriguingly, we ﬁnd that Tbx2misexpression has little or no
comparable effect on Tbx20 in the posterior portion of the heart tube,
emphasising that the regulatory interactions between these twoT-box
factors are region-speciﬁc.
Another family of proteins that may mediate the suppression of
cell proliferation by Tbx2 are those of NDRG family (Qu et al., 2002;
Zhou et al., 2001). Ndrg2 is a tumour suppressor, inhibiting cell
proliferation when overexpressed in a human glioblastoma cell line
(Deng et al., 2003). In the mouse, expression of Ndrg2 at E9.5 is
remarkably similar to that of Tbx2 (Okuda and Kondoh, 1999b), being
restricted to the non-chamber myocardium. Our ﬁnding that Ndrg2
expression is upregulated in Tbx2misexpressing heart points to a role
for this protein in mediating suppression of myocardial proliferation
by Tbx2 within the non-chamber myocardium. The related family
member Ndrg1 is a target for transcriptional repression by N-myc1
(Shimono et al., 1999) but whilst human Ndrg2 is a target of N-myc1
(Zhang et al., 2006), Ndrg2 transcription is unaffected in the N-myc1
null mouse (Okuda and Kondoh, 1999a), nor is the mouse Ndrg2 basal
promoter repressed by N-myc1 in vitro (Zhang et al., 2006). Another
NDRG family member, Ndrg4, has already been implicated in
regulating heart development. Loss of Ndrg4 function in the zebraﬁsh
embryo results in reduced myocardial proliferation and growth (Qu et
al., 2008) suggesting that in contrast to Ndrg2, this member of the
NDRG family acts as a positive regulator of myocardial proliferation.
Our ﬁnding that Ndrg4 expression is downregulated in the embryonic
mouse heart after Tbx2 misexpression suggests that in normal
development, Tbx2 regulates differential proliferation of chamber
versus non-chamber myocardium, at least in part, by regulating the
expression of both Ndrg2 and Ndrg4.
How may Tbx2 misexpression affect Ndrg2 and Ndrg4 in opposite
ways? Previous work has already indicated that Tbx2-mediated gene
regulation can be context dependant, suggesting that Tbx2 may
function as both activator and repressor (Chen et al., 2001).
Furthermore, in transcription assays, the presence of a single cis-
acting element resulted in Tbx2-mediated transcriptional repression,
whilst ﬁve, multimerised, cis-acting elements resulted in transcrip-
tional activation (Paxton et al., 2002). The proximal promoter regions
of Ndrg2 and Ndrg4 both contain multiple conserved T-box binding
elements (Fig. S6) and it is therefore possible that Tbx2 represses
transcription of one Ndrg gene whilst activating the other.
Defective deployment of secondary heart ﬁeld cells
An intriguing ﬁnding of our study is the reduction in Isl1+ cardiac
progenitor cells from the splanchnic mesoderm that is observed in the
OFT region of Tbx2-misexpressing hearts. Since this is not accom-
panied by any discernable increase in apoptosis, either in the
pharyngeal region or the OFT itself, it indicates that expression ofthe Tbx2 transgene inhibits deployment of SHF cells into the anterior
portion of the developing heart tube.
How might Tbx2 expression affect SHF deployment? Several
diverse lines of evidence have already implicated T-box factors in
regulating some aspect of cell movement or migration. For example,
in chicken, modiﬁcation of Tbx5 gene dosage inhibits proepicardial
cell migration in a cell-autonomous manner (Hatcher et al., 2004);
in zebraﬁsh embryo ectoderm, Tbx2b-deﬁcient cells show cell-
autonomous defects in cell movement during formation of the
neural plate (Fong et al., 2005); and the Tbx20 mutant mouse
displays an assortment of motor neuron migration defects (Song
et al., 2006). The incorporation of pharyngeal mesoderm into the
arterial and venous poles of the heart is not of course the result of
simple cell migration, since cardiogenic mesoderm is believed to
comprise an epithelial sheet. Nevertheless, there is extensive
movement of cardiac precursors from a caudal proliferative centre
during their addition to the developing OFT (van den Berg et al.,
2009) and it remains unclear to what extent such movements are
speciﬁc to cardiac precursors, moving relative to adjacent tissues, or
whether they are part of more general morphogenetic movements
associated with embryo growth. In either case, it is conceivable that
such movements share a comparable dependance on Tbx-regulated
cell surface properties.
In the zebraﬁsh embryo, Tbx2b-deﬁcient cells show altered cell
surface properties and reduced expression of the transmembrane
cadherin proteins (Fong et al., 2005), indicating that the effect may
result from a defect in cell–cell contact. In ourmodel, misexpression of
Tbx2 results in downregulation of N-cadherin and the resulting
changes in cell–cell contact could be responsible for the defect in heart
tube elongation. Consistent with this, N-cadherin is essential for
proper heart formation in the mouse and heart morphology of
embryos lacking N-cadherin is reminiscent of that we obtain by Tbx2
misexpression (Radice et al., 1997).
In addition to N-cadherin, we have found that expression of the
cell adhesion protein Alcam/CD166/DM-GRASP is also reduced
throughout the early heart tube after Tbx2 misexpression, especially
within the OFT region. Alcam a transmembrane protein of the
neuronal immunoglobulin superfamily is known to be involved in a
variety of biological processes, including axon guidance, haemato-
poiesis, immune response and invasive tumour growth (Lunter
et al., 2005; Ohneda et al., 2001; Weiner et al., 2004; Zimmerman
et al., 2006). During mouse embryogenesis, Alcam is expressed from
the cardiac crescent stage to E12.5 (Hirata et al., 2006). Expression
has also been documented in zebraﬁsh embryos (Gessert et al.,
2008; Weiner et al., 2004) and loss of DM-GRASP function in Xe-
nopus embryos results in defective cardiac morphogenesis (Gessert
et al., 2008; Weiner et al., 2004). Alcam null mice are viable and
fertile without any cardiovascular abnormality (Weiner et al., 2004),
suggesting functional compensation by another cell adhesion
protein. Interestingly, human clinical studies have identiﬁed a
small chromosomal microdeletion (3q13.11–q13.12) that contains
Alcam and presents a distinct clinical cardiac phenotype (Tetralogy
of Fallot; Simovich et al., 2008).
Whether reduction in other cell surface proteins in addition to
N-cadherin and Alcam contribute to the reduced deployment of SHF
cells, the precise mechanism remains puzzling since in our model, the
Tbx2 transgene is not expressedwithin the pharyngeal mesoderm, but
only within the heart tube. There are two ways to account for this.
Tbx2 expression may alter the cellular environment of the OFT region
(via an effect on cell surface proteins such as N-cadherin and Alcam),
making it less receptive to cells of the secondary heart ﬁeld.
Alternatively (or in addition), Tbx2 misexpression may affect cell
signalling from the heart tube which, in turn, inﬂuences SHF cells in
the pharyngeal mesoderm.
Soluble factors, such as member of the BMP family are involved in
differentiation of the myocardium and in regulation of the SHF (van
130 L. Dupays et al. / Developmental Biology 333 (2009) 121–131Wijk et al., 2007). Moreover, they have been shown to be regulated by
T-box factors during limb development (Suzuki et al., 2004). Synthesis
of such soluble factors may be affected by Tbx2 misexpression in the
heart tube, thereby affecting cell-signalling pathways involved in
recruitment and differentiation of cells from the SHF. A precedent for
such an indirect effect may be provided by the recent ﬁnding that
expression of Tbx3 in the pharyngeal endoderm and neural crest cells
is necessary for normal contribution of the closely associated SHF
progenitors to the arterial pole of the mouse heart (Mesbah et al.,
2008). Bmp4 expression does not appear to be altered in the Tbx2-
misexpressing heart (Fig. S5) but we have not yet examined other
members of the TGFβ family.
Tbx2 and normal development
Our misexpression model shows that Tbx2 is capable of severely
impairing cardiac growth of the heart tube, through combined effects
on myocardial proliferation and SHF deployment. Could Tbx2 regulate
comparable events in normal development? Certainly, Tbx2 is
expressed in the posterior part of the cardiac tube at E8.5 and its
expression only extends to include the OFT region somewhat later, at
E9.5. Deployment of Isl1+ cells from the anterior heart ﬁeld into the
heart appears to be reduced at the same time (Sun et al., 2007) and it
is tempting to speculate that the two events are indeed causally
linked. Furthermore, the ability of Tbx2 to repress myocardial
proliferation via its effects on the NDRG family members Ndrg2 and
Ndrg4 could account for the low proliferation of the non-chamber
myocardium compared with the greater proliferation of the forming
myocardial chambers.
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